top of page
Phase I & II Complete QMS package
Phase I & II Complete QMS package
Phase I & II Complete QMS package

Phase I & II Complete QMS package

€9,985.00Price
Excluding VAT

The Complete QMS Template Package from OZQA provides a fully written, inspection-ready documentation system designed specifically for biotech and life science companies in preclinical development and Phase I–II clinical trials.

 

The package includes all 13 core SOPs required to operate a compliant Quality Management System (QMS), as well as 12 supporting log forms needed to document training, deviations, CAPAs, change control, vendor oversight, complaint handling, and regulatory updates.

 

Every document in the package is professionally written, pre-filled, and 90–99% complete, requiring only minimal customization such as your company name and QA approver.
They are aligned with GxP, ICH, EMA, and FDA expectations and developed by QA experts with real inspection experience.

 

This complete QMS package allows startup and early-phase biotech organizations to build a compliant, scalable and inspection-ready quality system within days instead of months — without relying on expensive consulting hours.

 

Whether you are preparing for your first clinical trial, establishing sponsor oversight, or building the foundation for GMP operations, this package gives you everything you need to put a compliant QMS in place quickly and confidently.

 

All documents are editable Word files, ready for integration into your QMS or electronic QMS platform.

 

The Phase I/II Complete package includes 13 fully written SOPs and 12 log forms :

 

Quality Manual

An updated Quality Manual reflecting the expanded scope, responsibilities and quality processes associated with clinical development.

 

Document Manangement

Establishes how controlled documents are created, reviewed, approved, revised, distributed and archived.

 

Training and Organisation SOP

Defines organisational responsibilities and ensures personnel are appropriately qualified and trained for their assigned activities.

 

Vendor Management SOP

Provides a structured approach to selecting, qualifying, monitoring and overseeing external vendors and service providers.

 

Risk Management SOP

Establishes a consistent, risk based approach for identifying, evaluating, controlling and reviewing quality risks.

 

Archiving SOP

Defines requirements for secure retention, retrieval, protection and disposal of quality records and documentation.

 

Recall SOP

Defines how potential all investigational medicinal products (IMP) recalls are assessed, coordinated, documented and escalated when required.

 

Product Complaints SOP

Establishes a controlled process for receiving, assessing, investigating and documenting IMP product quality complaints.

 

Safety Reporting SOP

Defines responsibilities and processes for safety information and reporting during clinical development, including oversight of relevant outsourced activities.

 

Monitoring New Regulations SOP

Establishes a systematic approach for identifying, assessing and implementing relevant changes to regulations, guidelines and regulatory expectations.

 

Change Control SOP

Provides a structured process for assessing, approving, implementing and documenting changes that may affect quality, compliance or clinical activities.

 

CAPA SOP

Defines how quality issues are investigated and how corrective and preventive actions are identified, implemented, followed up and documented.

 

Serious Breach SOP

Establishes the process for identifying, assessing, escalating and reporting potential serious breaches related to clinical trials.

  • Suitable companies

    The Phase I/II Complete QMS is particularly suitable for:

    • Biotech and pharmaceutical companies establishing their first QMS
    • Companies preparing for their first Phase I clinical trial
    • Organisations progressing from preclinical into clinical development
    • Virtual and highly outsourced biotech companies
    • Sponsors working extensively with CROs and specialised vendors
    • Companies that want a scalable QMS without unnecessary complexity
  • What’s included

    ✓ 13 fully written SOPs
    ✓ 12 template log forms

    ✓ Core QMS + Phase I/II quality processes
    ✓ Editable documents
    ✓ Ready for company specific customisation
    ✓ Expandable for Phase III and later development

  • Benefits

     

    • Save 3–6 months of documentation work

    • Achieve inspection readiness rapidly

    • Avoid costly consultant hours

    • Ensure consistent, GxP-aligned documentation

    • Build investor confidence with a robust QMS

    • Scale smoothly into Phase III and commercialization

bottom of page